NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

LTFU for All Cell and Gene Therapy Studies

NCT06194461

Not Yet RecruitingN/A

Sponsor: AstraZeneca

Conditions: Hepatocellular Carcinoma, Prostate Cancer

Interventions: AZD5851, AZD0754

Countries: United States, Australia, Japan, South Korea

Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.

Eligibility overview

Sex: ALL

Age: 18 Years to 130 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. The participant has received a cell or gene therapy in another AstraZeneca protocol.
2. Provision of signed and dated, written informed consent before any study-specific procedures.

Exclusion Criteria:

Not applicable

\-

Locations (25)

Phoenix, Arizona, United States
Duarte, California, United States
Orange, California, United States
San Francisco, California, United States
Washington D.C., District of Columbia, United States
Jacksonville, Florida, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Westwood, Kansas, United States
Rochester, Minnesota, United States
St Louis, Missouri, United States
Hackensack, New Jersey, United States
New York, New York, United States
Columbus, Ohio, United States
Portland, Oregon, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Houston, Texas, United States
East Melbourne, Australia
Kashiwa, Japan
Kyoto, Japan
Osakasayama-shi, Japan
Seoul, South Korea
Seoul, South Korea
Seoul, South Korea